U.S. Markets closed
  • S&P 500

    3,662.45
    +40.82 (+1.13%)
     
  • Dow 30

    29,823.92
    +185.28 (+0.63%)
     
  • Nasdaq

    12,355.11
    +156.37 (+1.28%)
     
  • Russell 2000

    1,836.05
    +16.23 (+0.89%)
     
  • Crude Oil

    44.40
    -0.94 (-2.07%)
     
  • Gold

    1,813.90
    +38.20 (+2.15%)
     
  • Silver

    24.06
    +1.52 (+6.75%)
     
  • EUR/USD

    1.2080
    +0.0146 (+1.2201%)
     
  • 10-Yr Bond

    0.9340
    +0.0900 (+10.66%)
     
  • Vix

    20.77
    +0.20 (+0.97%)
     
  • GBP/USD

    1.3421
    +0.0089 (+0.6711%)
     
  • USD/JPY

    104.2940
    -0.0300 (-0.0288%)
     
  • BTC-USD

    19,130.63
    -269.13 (-1.39%)
     
  • CMC Crypto 200

    375.59
    -4.27 (-1.13%)
     
  • FTSE 100

    6,384.73
    +118.54 (+1.89%)
     
  • Nikkei 225

    26,787.54
    +353.92 (+1.34%)
     

Flexion Therapeutics soars on FDA label change approval

Flexion Therapeutics shares are soaring, after the FDA approved a label change for Zilretta, a treatment for osteoarthritis knee pain. Yahoo Finance's Anjalee Khemlani joins Seana Smith on The Ticker to discuss.